Swedish Orphan Biovitrum Ab (BIOVF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BIOVF | ASND | EXEL | ||
| Company | Swedish Orphan Biovitrum Ab | Ascendis Pharma ADR | Exelixis Inc | ||
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | ||
| Open | 35.2500 | 209.46 | 44.20 | ||
| High | 35.2500 | 212.00 | 44.59 | ||
| Low | 35.2500 | 204.94 | 43.85 | ||
| Latest | 35.2500 | 205.44 | 44.36 | ||
| Change | +0.3700 | -3.14 | -0.01 | ||
| % Change | +1.06% | -1.51% | -0.02% | ||
| Volume | 600 | 470,800 | 2,193,700 | ||
| 20-Day Average Volume | 480 | 646,960 | 2,516,330 | ||
| Previous Close | 34.8800 | 208.58 | 44.37 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 30.0113 | 206.82 | 42.88 | ||
| 20-Day Raw Stochastic | 99.89% | 49.46% | 89.17% | ||
| 20-Day Relative Strength | 62.23 | 50.24 | 61.69 | ||
| Weighted Alpha | N/A | +53.06 | +21.61 | ||
| Today's Opinion | N/A | 80% Buy | 88% Buy | ||
| Previous Opinion | N/A | 96% Buy | 88% Buy | ||
| Last Month's Opinion | N/A | 64% Buy | 8% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +15.35% since 08/29/25 | -3.24% since 11/28/25 | +0.43% since 11/28/25 | ||
| Low | 29.1800 on 09/04/25 | 198.30 on 12/03/25 | 43.00 on 12/02/25 | ||
| High | 35.2600 on 11/04/25 | 213.45 on 12/01/25 | 44.79 on 12/04/25 | ||
| 1-Month | |||||
| %Chg | +5.86% since 10/06/25 | +3.89% since 11/05/25 | +9.88% since 11/05/25 | ||
| Low | 34.8800 on 11/04/25 | 188.07 on 11/13/25 | 39.83 on 11/10/25 | ||
| High | 35.2600 on 11/04/25 | 223.18 on 11/17/25 | 44.91 on 11/28/25 | ||
| 3-Month | |||||
| %Chg | +15.35% since 08/29/25 | -0.23% since 09/05/25 | +17.11% since 09/05/25 | ||
| Low | 29.1800 on 09/04/25 | 186.05 on 10/20/25 | 33.76 on 10/20/25 | ||
| High | 35.2600 on 11/04/25 | 223.18 on 11/17/25 | 44.91 on 11/28/25 | ||
| 6-Month | |||||
| %Chg | +16.38% since 05/23/25 | +15.71% since 06/05/25 | +4.70% since 06/05/25 | ||
| Low | 27.0600 on 06/20/25 | 160.86 on 07/29/25 | 33.76 on 10/20/25 | ||
| High | 35.2600 on 11/04/25 | 223.18 on 11/17/25 | 49.62 on 06/23/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 12,549,000 | 12,674,619 | 11,893,449 | ||
| Shares Outstanding, K | 356,000 | 61,695 | 268,112 | ||
| Annual Sales | 2,462,150,000 | 393,500,000 | 2,168,700,000 | ||
| Annual Net Income | 367,520,000 | -409,120,000 | 521,270,000 | ||
| Last Quarter Sales | 817,260,000 | 249,720,000 | 597,760,000 | ||
| Last Quarter Net Income | -304,160,000 | -71,290,000 | 193,580,000 | ||
| 60-Month Beta | 0.38 | 0.45 | 0.40 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.64 on 10/20/25 | -1.17 on 11/12/25 | 0.78 on 11/04/25 | ||
| Latest Earnings Date | 10/23/25 | 11/12/25 | 11/04/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 23.10 | 0.00 | 19.04 | ||